Cargando…

Diagnostic value and characteristic analysis of serum nucleocapsid antigen in COVID-19 patients

BACKGROUND: To date, several types of laboratory tests for coronavirus disease 2019 (COVID-19) diagnosis have been developed. However, the clinical importance of serum severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleocapsid antigen (N-Ag) remains to be fully elucidated. In this stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xihong, Qian, Chungen, Yang, Li, Gao, Huixia, Jiang, Ping, Dai, Muwei, Wang, Yuling, Kang, Haiyan, Xu, Yi, Hu, Qian, Feng, Fumin, Cheng, Bangning, Dai, Erhei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257392/
https://www.ncbi.nlm.nih.gov/pubmed/37304882
http://dx.doi.org/10.7717/peerj.15515
_version_ 1785057292019826688
author Zhang, Xihong
Qian, Chungen
Yang, Li
Gao, Huixia
Jiang, Ping
Dai, Muwei
Wang, Yuling
Kang, Haiyan
Xu, Yi
Hu, Qian
Feng, Fumin
Cheng, Bangning
Dai, Erhei
author_facet Zhang, Xihong
Qian, Chungen
Yang, Li
Gao, Huixia
Jiang, Ping
Dai, Muwei
Wang, Yuling
Kang, Haiyan
Xu, Yi
Hu, Qian
Feng, Fumin
Cheng, Bangning
Dai, Erhei
author_sort Zhang, Xihong
collection PubMed
description BACKGROUND: To date, several types of laboratory tests for coronavirus disease 2019 (COVID-19) diagnosis have been developed. However, the clinical importance of serum severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleocapsid antigen (N-Ag) remains to be fully elucidated. In this study, we sought to investigate the value of serum SARS-CoV-2 N-Ag for COVID-19 diagnosis and to analyze N-Ag characteristics in COVID-19 individuals. METHODS: Serum samples collected from 215 COVID-19 patients and 65 non-COVID-19 individuals were used to quantitatively detect N-Ag via chemiluminescent immunoassay according to the manufacturer’s instructions. RESULTS: The sensitivity and specificity of the N-Ag assay were 64.75% (95% confidence interval (95% CI) [55.94–72.66%]) and 100% (95% CI [93.05–100.00%]), respectively, according to the cut-off value recommended by the manufacturer. The receiver operating characteristic (ROC) curve showed a sensitivity of 100.00% (95% CI [94.42–100.00%]) and a specificity of 71.31% (95% CI [62.73–78.59%]). The positive rates and levels of serum SARS-CoV-2 N-Ag were not related to sex, comorbidity status or disease severity of COVID-19 (all P < 0.001). Compared with RT‒PCR, there was a lower positive rate of serum N-Ag for acute COVID-19 patients (P < 0.001). The positive rate and levels of serum SARS-CoV-2 N-Ag in acute patients were significantly higher than those in convalescent patients (all P < 0.001). In addition, the positive rate of serum SARS-CoV-2 N-Ag in acute COVID-19 patients was higher than that of serum antibodies (IgM, IgG, IgA and neutralizing antibodies (Nab)) against SARS-CoV-2 (all P < 0.001). However, the positive rate of serum SARS-CoV-2 N-Ag in convalescent COVID-19 patients was significantly lower than that of antibodies (all P < 0.001). CONCLUSION: Serum N-Ag can be used as a biomarker for early COVID-19 diagnosis based on appropriate cut-off values. In addition, our study also demonstrated the relationship between serum N-Ag and clinical characteristics.
format Online
Article
Text
id pubmed-10257392
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher PeerJ Inc.
record_format MEDLINE/PubMed
spelling pubmed-102573922023-06-11 Diagnostic value and characteristic analysis of serum nucleocapsid antigen in COVID-19 patients Zhang, Xihong Qian, Chungen Yang, Li Gao, Huixia Jiang, Ping Dai, Muwei Wang, Yuling Kang, Haiyan Xu, Yi Hu, Qian Feng, Fumin Cheng, Bangning Dai, Erhei PeerJ Immunology BACKGROUND: To date, several types of laboratory tests for coronavirus disease 2019 (COVID-19) diagnosis have been developed. However, the clinical importance of serum severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleocapsid antigen (N-Ag) remains to be fully elucidated. In this study, we sought to investigate the value of serum SARS-CoV-2 N-Ag for COVID-19 diagnosis and to analyze N-Ag characteristics in COVID-19 individuals. METHODS: Serum samples collected from 215 COVID-19 patients and 65 non-COVID-19 individuals were used to quantitatively detect N-Ag via chemiluminescent immunoassay according to the manufacturer’s instructions. RESULTS: The sensitivity and specificity of the N-Ag assay were 64.75% (95% confidence interval (95% CI) [55.94–72.66%]) and 100% (95% CI [93.05–100.00%]), respectively, according to the cut-off value recommended by the manufacturer. The receiver operating characteristic (ROC) curve showed a sensitivity of 100.00% (95% CI [94.42–100.00%]) and a specificity of 71.31% (95% CI [62.73–78.59%]). The positive rates and levels of serum SARS-CoV-2 N-Ag were not related to sex, comorbidity status or disease severity of COVID-19 (all P < 0.001). Compared with RT‒PCR, there was a lower positive rate of serum N-Ag for acute COVID-19 patients (P < 0.001). The positive rate and levels of serum SARS-CoV-2 N-Ag in acute patients were significantly higher than those in convalescent patients (all P < 0.001). In addition, the positive rate of serum SARS-CoV-2 N-Ag in acute COVID-19 patients was higher than that of serum antibodies (IgM, IgG, IgA and neutralizing antibodies (Nab)) against SARS-CoV-2 (all P < 0.001). However, the positive rate of serum SARS-CoV-2 N-Ag in convalescent COVID-19 patients was significantly lower than that of antibodies (all P < 0.001). CONCLUSION: Serum N-Ag can be used as a biomarker for early COVID-19 diagnosis based on appropriate cut-off values. In addition, our study also demonstrated the relationship between serum N-Ag and clinical characteristics. PeerJ Inc. 2023-06-07 /pmc/articles/PMC10257392/ /pubmed/37304882 http://dx.doi.org/10.7717/peerj.15515 Text en © 2023 Zhang et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.
spellingShingle Immunology
Zhang, Xihong
Qian, Chungen
Yang, Li
Gao, Huixia
Jiang, Ping
Dai, Muwei
Wang, Yuling
Kang, Haiyan
Xu, Yi
Hu, Qian
Feng, Fumin
Cheng, Bangning
Dai, Erhei
Diagnostic value and characteristic analysis of serum nucleocapsid antigen in COVID-19 patients
title Diagnostic value and characteristic analysis of serum nucleocapsid antigen in COVID-19 patients
title_full Diagnostic value and characteristic analysis of serum nucleocapsid antigen in COVID-19 patients
title_fullStr Diagnostic value and characteristic analysis of serum nucleocapsid antigen in COVID-19 patients
title_full_unstemmed Diagnostic value and characteristic analysis of serum nucleocapsid antigen in COVID-19 patients
title_short Diagnostic value and characteristic analysis of serum nucleocapsid antigen in COVID-19 patients
title_sort diagnostic value and characteristic analysis of serum nucleocapsid antigen in covid-19 patients
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257392/
https://www.ncbi.nlm.nih.gov/pubmed/37304882
http://dx.doi.org/10.7717/peerj.15515
work_keys_str_mv AT zhangxihong diagnosticvalueandcharacteristicanalysisofserumnucleocapsidantigenincovid19patients
AT qianchungen diagnosticvalueandcharacteristicanalysisofserumnucleocapsidantigenincovid19patients
AT yangli diagnosticvalueandcharacteristicanalysisofserumnucleocapsidantigenincovid19patients
AT gaohuixia diagnosticvalueandcharacteristicanalysisofserumnucleocapsidantigenincovid19patients
AT jiangping diagnosticvalueandcharacteristicanalysisofserumnucleocapsidantigenincovid19patients
AT daimuwei diagnosticvalueandcharacteristicanalysisofserumnucleocapsidantigenincovid19patients
AT wangyuling diagnosticvalueandcharacteristicanalysisofserumnucleocapsidantigenincovid19patients
AT kanghaiyan diagnosticvalueandcharacteristicanalysisofserumnucleocapsidantigenincovid19patients
AT xuyi diagnosticvalueandcharacteristicanalysisofserumnucleocapsidantigenincovid19patients
AT huqian diagnosticvalueandcharacteristicanalysisofserumnucleocapsidantigenincovid19patients
AT fengfumin diagnosticvalueandcharacteristicanalysisofserumnucleocapsidantigenincovid19patients
AT chengbangning diagnosticvalueandcharacteristicanalysisofserumnucleocapsidantigenincovid19patients
AT daierhei diagnosticvalueandcharacteristicanalysisofserumnucleocapsidantigenincovid19patients